Osteoblast Receptors

Advances in Organ Biology

Volumn 5, Issue C, 1998, Pages 499-512

  Henderson, Janet E ^a   Goltzman, David ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 17544375198     PISSN: 15692590     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-2590(08)60132-9     Document Type: Article

References (49)

1. Abou-Samra A.B., Jüppner H., Force T., Freeman M.W., Kong X.F., Schipani E., Urena P., Richards J., Bonventre J.V., Potts Jr. J.T., Kronenberg H.M., and Segre G.V. Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblastlike cells: A single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc. Natl. Acad. Sci. USA 89 (1992) 2732-2736
2. Allan E.H., Zeheb R., Gelehrter T.D., Heaton J.H., Fukumoto S., Yee J.A., and Martin T.J. Transforming growth factor β inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA and protein in rat osteoblastlike cells. J. Cell Physiol. 149 (1991) 34-43
3. Amizuka N., Karaplis A.C., Henderson J.E., Warshawsky H., Lipman M.L., Matsuki Y., Ejiri S., Tanaka M., Izumi N., Ozawa H., and Goltzman D. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev. Biol. 175 (1995) 166-176
4. Andress D.L., and Birnbaum R.S. Human osteoblast-derived insulinlike growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J. Biol. Chem. 267 (1992) 22467-22472
5. Attisano L., Wrana J.L., Lopez-Casillas F., and Massague J. TGF-β receptors and actions. Biochim Biophys Acta 1222 (1994) 71-80
6. + exchanger NHE-1 isoform in osteoblastic cells (UMR-106) via a cAMP-dependent pathway. J. Biol. Chem. 270 (1995) 23166-23172
7. Baylink D.J., Finkelman R.D., and Mohan S. Growth factors to stimulate bone formation. J. Bone Miner. Res. 8 (1993) S565-S572
8. Bonewald L.F., and Dallas S.L. Role of active and latent transforming growth factor β in bone formation. J. Cell Biochem. 55 (1994) 350-357
9. Canalis E. Regulation of bone remodelling. In: Favus M.J. (Ed). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism (1993), Raven Press, New York 33-37
10. Centrella M., Casinghino S., Kim J., Pham T., Rosen V., Wozney J., and McCarthy T.L. Independent changes in type-I and type-II receptors for transforming growth factor β induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype. Mol. Cell Biol. 15 (1995) 3273-3281
11. Chorev M., and Rosenblatt M. Structure-function analysis of parathyroid hormone and parathyroid hormone-related protein. In: Bilezekian J.P., Marcus R., and Levine M.A. (Eds). The parathyroids: Basic and clinical aspects (1994), Raven Press, New York 139-156
12. Clark E.A., and Brugge J.S. Integrins and signal transduction pathways: The road taken. Science 268 (1995) 233-239
13. Delaney A.M., Dong Y., and Canalis E. Mechanism of glucocorticoid action in bone cells. J. Cell Biochem. 56 (1994) 295-302
14. Franchimont N., and Canalis E. Soluble interleukin-6 receptor (sIL-6r) enhances the transcriptional autoregulation of interleukin-6 (IL-6) in osteoblasts. J. Bone Miner. Res. 10 (1995) S159
15. Grigoriadis A.E., Heersche Y.N.M., and Aubin J.E. Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: Effect of dexamethasone. J. Cell Biol. 106 (1988) 2139-2151
16. Hibi M., Nakajima K., and Hirano T. IL-6 cytokine family and signal transduction: A model of the cytokine system. J. Mol. Med. 74 (1996) 1-12
17. Hock J.M., Fonesca J., Gunness-Hey M., Kemp B.E., and Martin T.J. Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1 -34 and PTH 1 -34 on bone in rats. Endocrinology 125 (1989) 2022-2027
18. Kawaguchi H., Pilbeam C.C., Harrison J.R., and Raisz L.G. The role of prostaglandins in the regulation of bone metabolism. Clin. Ortho. Rel. Res. 313 (1995) 36-46
19. Klagsbrun M., and Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell 67 (1991) 229-231
20. Kremer R., Sebag M., Champigny C., Meerovitch K., Hendy G.N., White J., and Goltzman D. Identification and characterization of 1,25-dihydroxyvitamin D3-responsive repressor sequences in the rat parathyroid hormone-related peptide gene. J. Biol. Chem. 271 (1996) 16310-16316
21. Lutticken C., Wegenka U.M., Yuan J., Buschmann J., Schindler C., Ziemiecki A., Harpur A.G., Wilks A.F., Yasukawa K., Taga T., Kishimoto T., Barbieri G., Pellegrini S., Sendtner M., Heinrich P.C., and Horn F. Association of transcription factor APRF and protein kinase Jak 1 with the interleukin-6 signal transducer gp 130. Science 263 (1993) 89-92
22. Malaval L., Gupta A.K., and Aubin J.E. Leukemia inhibitory factor inhibits osteogenic differentiation in rat calvaria cell cultures. Endocrinology 136 (1995) 1411-1418
23. Manolagas S.C., and Jilka R.J. Bone marrow cytokines and bone remodeling. N. Engl. J. Med. 332 (1995) 305-311
24. Marx J. Forging a path to the nucleus. Science 260 (1993) 1588-1590
25. Massagué J., Hata A., and Liu F. TGF-β signaling through the Smad pathway. Trends Cell Biol. 7 (1997) 187-192
26. Migliaccio S., Wetsel W.C., Fox W.M., Washburn T.F., and Korach K.S. Endogenous protein kinase-C activation in osteoblastlike cells modulates responsiveness to estrogen and estrogen receptor levels. Mol. Endocrinol. 7 (1993) 1133-1143
27. Muenke M., and Schell U. Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet. 11 (1995) 308-313
28. Ornitz D.M., and Leder P. Ligand specificity and heparin dependence of fibroblast growth factors 1 and 3. J. Biol. Chem. 267 (1992) 16305-16311
29. Parsons J.T. Integrin-mediated signaling: Regulation by protein tyrosine kinases and small GTP-binding proteins. Curr. Opin. Cell Biol. 8 (1996) 146-152
30. Partridge N.C., Kemp B.E., Livesey S.A., and Martin T.J. Activity ratio measurements reflect intracellular activation of adenosine 3′,5′-monophosphate-dependent protein kinase in osteoblasts. Endocrinology 111 (1982) 178-183
31. Pausova Z., Bourdon J., Clayton D., Mattei M.G., Seldin M.F., Janicic N., Riviere M., Szpirer J., Levan G., Szpirer C., Goltzman D., and Hendy G.N. Cloning of a parathyroid hormone/parathyroid hormone-related peptide (PTHrP) receptor cDNA from a rat osteosarcoma (UMR 106) cell line. Genomics 20 (1994) 20-26
32. Rabbani S.A., Desjardins J., Bell A.W., Banville D., and Goltzman D. An amino-terminal fragment of urokinase isolated from a prostatic cancer cell line (PC-3) is mitogenic for osteoblastlike cells. Biochem. Biophys. Res. Comm. 173 (1991) 1058-1064
33. Rabbani S.A., Mazar A.P., Bernier S.M., Haq M., Bolivar I., Henkin J., and Goltzman D. Structural requirements for the growth factor activity of the amino-terminal domain of urokinase. J. Biol. Chem. 267 (1992) 14151-14156
34. Reddi A.H. Bone morphogenetic proteins, bone marrow stromal cells, and mesenchymal stem cells. Clin. Orthop. Rel. Res. 313 (1995) 115-119
35. Rodan G.A., and Martin T.J. Role of osteoblasts in hormonal control of bone resorption-a hypothesis. Calcified Tiss. Int. 33 (1981) 349-351
36. Romas E., Udagawa N., Hilton D.J., Martin T.J., and Ng K.W. Osteotropic factors regulate interleukin-11 production by osteoblasts. J. Bone Miner. Res. 10 (1995) S142
37. Rouleau M.F., Mitchell J., and Goltzman D. In vivo distribution of parathyroid hormone receptors in bone: Evidence that a predominant target osseous cell is not the mature osteoblast. Endocrinology 123 (1988) 187-191
38. Rouleau M.F., Mitchell J., and Goltzman D. Characterization of the major parathyroid hormone target cell in the endosteal metaphysis of rat long bones. J. Bone Miner. Res. 5 (1990) 1043-1053
39. Segre G.V. Receptors for parathyroid hormone and parathyroid hormone-related protein. In: Bilezekian J.P., Marcus R., and Levine M.A. (Eds). The Parathyroids: Basic and Clinical Aspects (1994), Raven Press, New York 213-218
40. Siddhanti S.R., and Quarles L.D. Molecular to pharmacologic control of osteoblast proliferation and differentiation. J. Cell Biochem. 55 (1994) 310-320
41. Simon M.I., Strathmann M.P., and Gautam N. Diversity of G proteins in signal transduction. Science 252 (1991) 802-808
42. Stahl N., Farrugella T.J., Boulton T.G., Zhong Z., Darnell J.E., and Yancopoulos G. Choice of STATS and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267 (1995) 1349-1353
43. Takeuchi Y., Nakayama K., and Matsumoto T. Differentiation and cell surface expression of transforming growth factor-β receptors are regulated by interaction with matrix collagen in murine osteoblastic cells. J. Biol. Chem. 271 (1996) 3938-3944
44. Thompson D.D., Seedor J.G., Fisher J.E., Rosenblatt M., and Rodan G.A. Direct action of the parathyroid hormonelike human hypercalcemic factor on bone. Proc. Natl. Acad. Sci. USA 85 (1988) 5673-5677
45. Truss M., and Beato M. Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors. Endocrine Rev. 14 (1993) 459-475
46. Ullrich A., and Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 61 (1990) 203-212
47. Wen Z., Zhong Z., and Darnell J.E. Maximal activation of transcription by Statl and Stat3 requires both tyrosine and serine phosphorylation. Cell 82 (1995) 241-250
48. Yamaguchi K., Shirakabe K., Shibuya H., Irie K., Oishi I., Ueno N., Taniguchi T., Nishida E., and Matsumoto K. Identification ofa member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270 (1995) 2008-2011
49. Yamaji N., Celeste A.J., Thies R.S., Song J.J., Bernier S.M., Goltzman D., Lyons K.M., Nove J., Rosen V., and Wozney J.M. A mammalian serine/threonine kinase receptor specifically binds BMP-2 and BMP-4. Biochem. Biophys. Res. Comm. 205 (1994) 1944-1951